23:27:28 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



Aphria Inc
Symbol APH
Shares Issued 232,435,088
Close 2018-09-14 C$ 19.55
Market Cap C$ 4,544,105,970
Recent Sedar Documents

Aphria director Staudt resigns

2018-09-14 20:09 ET - News Release

Mr. Vic Neufeld reports

APHRIA ANNOUNCES DIRECTOR RESIGNATION AND APPOINTMENT

Aphria Inc.'s Dennis Staudt has resigned from the company's board of directors. Mr. Staudt served as lead independent director and chair of the audit committee, and he had been a member of the board since 2014, before the company was publicly traded.

"Dennis has been an integral part of Aphria since the company's infancy, and we are tremendously grateful for his dedicated service, counsel and guidance over the past four years," said Vic Neufeld, chief executive officer of Aphria. "We thank Dennis for his significant contribution to Aphria's incredible growth story and ongoing success, and we wish him well in his future endeavours."

The company has also announced that the board has approved the appointment of John Herhalt to replace Mr. Staudt as an independent director. Mr. Herhalt is a retired partner from KPMG and has over 39 years of experience providing a wide variety of advisory and audit services to a range of clients. He has also been appointed chair of the audit committee.

"We are pleased to welcome John to the Aphria family as a member of our board of directors," added Mr. Neufeld. "John brings a wealth of global experience across a broad base of industry sectors, including consumer products, health care, infrastructure and the public sector. Aphria will greatly benefit from his incredible knowledge, experience and strategic guidance."

The board will select a new lead independent director following the annual general meeting.

About Aphria Inc.

Aphria is a leading global cannabis company driven by an unrelenting commitment to its people, product quality and innovation. Headquartered in Leamington, Ont., the greenhouse capital of Canada, Aphria has been setting the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. Focusing on untapped opportunities and backed by the latest technologies, Aphria is committed to bringing breakthrough innovation to the global cannabis market. The company's portfolio of brands is grounded in expertly researched consumer insights designed to meet the needs of every consumer segment.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.